Introduction
Foodborne illness is as erious worldwide health concern.
[1] The increased rate of hospitalizations and deaths due to gastrointestinal disorders caused by bacterial infections has become as ignificant challenge for medical professionals. [2] Among the many pathogenic bacteria responsible for enteric diseases, Salmonellae nterica is predominant. [3] Salmonella speciesa re recognized as am ajor pathogen of both animals and humans, causing the foodborne illness salmonellosis. [4] Salmonella infections arise from the contamination of poultry,e ggs, beef, and other foods, sometimes from unwashed fruits and vegetables. [5] Severale nteric outbreaks caused by Salmonella have been witnessed recently in many countries. [6] There are several strains of S. enterica,w hich are classified by their cell wall Opolysaccharides. [7] Because these cell wall O-polysaccharides have ad irect influenceo nt he pathogenicity of Salmonella strains, [8] the structures of several O-polysaccharides from an umber of S. enterica strains have been elucidated. [7] Perepelov et al. [9] reported the structure of the repeating unit of the cell wall O-polysaccharideo fS. enterica strain O53;i ti satetrasaccharide composed of a-d-galactofuranose, b-d-galactosamine, 2,3-di-O-acetylated a-l-rhamnopyranose and b-d-glucosamine moieties.
Current efforts in medicinal chemistrya nd drug discovery programs involve the development of alternative approaches for the control of infections by antibiotic-resistantb acterial strains. [10] Although vaccines based on bacterial cell wall polysaccharides were introduced many years ago, these werei neffectivei nc hildren owing to the lack of aT -cell-independent immune response. Glycoconjugate vaccines were later developed, and were found to be highly effective in both adults and children. [11] Conventional glycoconjugate vaccines are prepared by using polysaccharides isolated from bacterialf ermentation. This approach has several serious drawbacks, including the handling of live bacterial strains, the presence of biological impurities, and batch-to-batch variations in the exact structure of the oligosaccharidee pitope.
As ynthetic oligosaccharidef ragment, corresponding to the entire polysaccharide with the appropriate structure, in conjugation with ap rotein could lead to an efficient glycoconjugate vaccinet hat circumventst he above-mentioned shortcomings. In this context,t he development of synthetic strategies fort he preparation of glycoconjugate derivatives against S. enterica O53 ando ther relateds trains would be of great interest. In many cases it has been found that the full-length oligosaccharide repeat unit is not essential for generating as ignificant immune response;asmallerf ragment can act as an immunodominantg lycan. [12, 13] The tetrasaccharide repeat unit of S. enterica O53 strain contains two O-acetyl groups that might influence the antigenicity of the molecule. We therefore decided to synthesize di-, tri-, and tetrasaccharide moieties corresponding to the repeat unit of the S. enterica O53 strain cell-wall polysaccharide, containing O-acetyl groups at the appropriate posiConventional glycoconjugate vaccines are prepared with polysaccharides isolated from bacterialf ermentation, an approach with some significantd rawbacks such as handling of live bacterial strains,t he presence of biological impurities, and interbatch variations in oligosaccharide epitope structure. However, it has been shown in many cases that as ynthetic fragment of appropriate structure conjugated to ap rotein can be an effective vaccine that circumvents the shortcomings of using fulllength oligosaccharides. The development of synthetic strategies to prepare glycoconjugate derivatives against pathogenic bacterials trains is therefore of great interest. Oligosaccharide fragments corresponding to the repeat unit of the cell wall O-antigen of Salmonella enterica strain O53 were synthesized in good yield. Sequential and block glycosylations trategies were used for the synthesis of the target compounds. A number of recently developed reaction conditions were used in the synthetic strategy.Ao ne-pot reactions cheme was also developed for the multiple glycosylations teps. The stereoselective outcomes of all glycosylation reactions were very good.
tions with a2 -aminoethyl linker connected to the reducing end. In addition, we developed ao ne-pot synthetic strategy for the synthesis of the tetrasaccharide derivative. The 2-aminoethyl linker can serve as ar eadily availablea mine functionality for connecting the synthetic glycan moietiest oas uitable protein through aspacerlinkage.
Results and Discussion
Because two O-acetyl groups are presenti nt he native structure of the O-polysaccharide, this synthetic strategy was designed for the synthesis of the target molecules with O-acetyl groups present at the appropriate positions. The oligosaccharide fragments 1, 2,a nd 3 were synthesized via stereoselective glycosylation of the suitably functionalized monosaccharide intermediates 4, [14] 5, [15] 6, [16] 7, [17, 18] and 8 by applying recently developed glycosylation conditions (Figure 1 ). Compound 3 was synthesized using [2 + 2] block glycosylation conditions as well as ao ne-pot two-step glycosylationa pproach. The monosaccharide derivatives were prepared from the commercially availabler educing sugars using published reactionc onditions. To prepare the 1,2-cis d-galactofuranosyl linkage in compound 12,p er-O-benzylated d-galactofuranosyl trichloroacetimidate derivative 7 (a/b 1:9) was used as the glycosyl donor, [18] which was prepared from 2,3,5,6-tetra-O-benzyl-a/b-d-galactofuranose [19] by treatment with trichloroacetonitrile in the presence of DBU, followingr eactionc onditions similar to those reported by Gandolfi-Donadío et al. [17] Disaccharide thioglycoside donor 12 was prepared by glycosylation of compound 7 with thioglycoside acceptor 6 in the presence of nitrosyl tetrafluoroborate (NOBF 4 )a st he glycosylation activator, [20] exploiting the orthogonal properties [21] of compound 6. Ethyl 3,4,6-tri-O-benzyl-2-deoxy-2-N-phthalimido-1-thio-b-dgalactopyranoside (8)w as prepared in 81 %y ield from the previously reported compound 6 [16] by benzylation using benzyl bromide and sodium hydride. [22] Iodonium-ion-promoted stereoselectiveg lycosylationo fc ompound 4 with thioglycoside derivative 5 in the presence of ac ombinationo fN-iodosuccinimide (NIS) and perchloric acid supported over silica (HClO 4 À SiO 2 ) [23, 24] furnished disaccharide derivative 9 in 77 %y ield. NMR spectrala nalysiso fc ompound 9 confirmed its formation CNMR spectra]. Compound 9 wass ubjected to as eries of functional group transformations, which include:a )treatment with hydrazine monohydrate at elevated temperature, [25] b) acetylation using acetic anhydride andp yridine, c) removal of the allyl ether by treatment with palladium chloride, [26] andd )catalytic transfer hydrogenation [27] using triethylsilanei nt he presence of Pearlman's catalystt of urnish compound 1 in 57 %o verall yield. Removal of the allyl ether from compound 9 with palladium chloride [26] gave the disaccharide acceptor 10 in 67 %y ield. Compound 10 was allowed to couple stereoselectively with thioglycoside derivative 8 in the presence of ac ombination of NIS andH ClO 4 ÀSiO 2 [23, 24] to furnish the trisaccharide derivative 11 in 70 %y ield. In another approach the tetrasaccharide 3 as its 2-aminoethyl glycoside was synthesized by applying a[ 2+ 2] block glycosylations trategy.S tereoselective glycosylation of the thioglycoside acceptor 6 with trichloroacetimidate derivative 7 in the presence of NOBF 4 [20] furnished the disaccharide thioglycoside derivative 12 in 65 %y ield, together with am inor quantity (~5%)o ft he other isomeric product, which was separated by columnc hromatography.T he stereochemistry of the glycosyl linkage was confirmed by its spectrala nalysis[ signals at d HNMR spectrum of compound 12 confirmedf ormation of the 1,2-cis d-galactofuranosyl linkage. [28] Stereoselective glycosylation of disaccharide thioglycoside donor 12 with disacchar- 13 CNMR spectra] (Scheme 2). In ap arallel set of experiments,t etrasaccharide derivative 13 was synthesized under two-stepo ne-pot reaction conditions. In this strategy,t hioglycoside 6 was allowed to react with d-galactofuranosyl trichloroacetimidate donor 7 in the presenceo fN OBF 4 until the starting materialsw ere consumed and an ew spot appeared in the TLC plate. Compound 10 was then added to the reaction mixture followed by NIS and HClO 4 ÀSiO 2 ,a nd the reactionw as continued to furnish compound 13 in 46 %o verall yield in one pot. Compound 13 was subjected to as imilar set of reactions used in the preparation of compound 1 from compound 9,t o furnish compound 3 in 50 %o verall yield (Scheme 3). The NMR spectrala nalysis of compound 3 confirmed its formation [signals at d 
Conclusions
In summary,o ligosaccharides corresponding to the cell wall Opolysaccharide of Salmonella enterica strain O53w ere synthesized, maintaining the exact structural components present in the native polysaccharide. The tetrasaccharide derivativew as also synthesized under one-pot reaction conditions. The stereoselectiveo utcome and yields were satisfactory in all glycosylations teps.
Experimental Section
General methods:A ll reactions were monitored by thin-layer chromatography over silica-gel-coated TLC plates. [24] Ethyl 3,4,6-tri-O-benzyl-2-deoxy-2-N-phthalimido-1-thio-b-d-galactopyranoside (8):T oas olution of compound 6 (1 g, 1.87 mmol) in anhydrous THF (15 mL) was added benzyl bromide (0.5 mL, 4.20 mmol) and the reaction mixture was cooled to 0 8C. To the cooled reaction mixture was added sodium hydride (60 %o il coated, 225 mg, 5.61 mmol) and it was stirred at 0 8Cf or 2h.T he reaction was quenched by the addition of saturated aqueous NH 4 Cl (50 mL), and then was extracted with CH 2 Cl 2 (50 mL). The organic layer was washed with H 2 O( 50 mL), dried (Na 2 SO 4 )a nd concentrated under reduced pressure. The crude product was purified over SiO 2 using hexane/EtOAc (9:1) as eluent to give pure compound 8 (945 mg, 81 % (9):T oasolution of compound 4 (1.5 g, 2.61 mmol) and compound 5 (1 g, 3.01 mmol) in dry toluene (20 mL) was added MS 4(2 g), and the reaction mixture was cooled to À15 8Cu nder argon. To the cooled reaction mixture were added NIS (750 mg, 3.33 mmol) and HClO 4 ÀSiO 2 (50 mg), and it was allowed to stir at same temperature for 40 min. The reaction mixture was filtered and washed with CH 2 Cl 2 (100 mL). The combined organic layer was successively washed with 5% Na 2 S 2 O 3 (100 mL), saturated NaHCO 3 (100 mL) and H 2 O( 100 mL), dried (Na 2 SO 4 )a nd concentrated. The crude product was purified over SiO 2 using hexane/EtOAc (5:1) as eluent to give pure compound 9 (1. , H-4 B ), 1.93, 1.74 (2 s, COCH 3 (10):T oas olution of compound 9 (1 g, 1.18 mmol) in anhydrous CH 3 OH (20 mL) was added PdCl 2 (125 mg, 0.70 mmol) and the reaction mixture was allowed to stir at room temperature for 1h.T he reaction mixture was filtered through aCelite bed and the filtering bed was washed with CH 3 OH (50 mL). The combined filtrate was concentrated to give the crude product, which was purified over SiO 2 using hexane/EtOAc (4:1) as eluent to give pure compound 10 (640 mg, 67 % (11):T oas olution of compound 10 (300 mg, 0.37 mmol) and compound 8 (260 g, 0.42 mmol) in dry CH 2 Cl 2 (8 mL) was added MS 4 (0.5 g) and the reaction mixture was cooled to À40 8Cu nder argon. To the cooled reaction mixture were added NIS (110 mg, 0.49 mmol) and HClO 4 À SiO 2 (10 mg) and it was allowed to stir at same temperature for 1h.T he reaction mixture was filtered and washed with CH 2 Cl 2 (50 mL). The combined organic layer was successively washed with 5% Na 2 S 2 O 3 (25 mL), saturated NaHCO 3 (25 mL) and H 2 O( 25 mL), dried (Na 2 SO 4 )a nd concentrated. The crude product was purified over SiO 2 using hexane/EtOAc 101.9 (PhCH), 98.9 (C1 A ), 97.6 (C1 C ), 97.0 (C1 B ), 80.0 (C4 A ) (12):Asolution of compound 6 (500 mg, 0.94 mmol) and compound 7 (800 mg, 1.17 mmol) in dry CH 2 Cl 2 (20 mL) was cooled to À20 8Cu nder argon. To the cooled reaction mixture was added NOBF 4 (80 mg, 0.68 mmol) and it was allowed to stir at same temperature for 1h.T he reaction mixture was poured into saturated NaHCO 3 (50 mL) and extracted with CH 2 Cl 2 (50 mL). The organic layer was washed with H 2 O( 50 mL), dried (Na 2 SO 4 )a nd concentrated. The crude product was purified over SiO 2 using hexane/EtOAc (13):T oasolution of compound 10 (300 mg, 0.37 mmol) and compound 12 (460 mg, 0.44 mmol) in dry CH 2 Cl 2 (10 mL) was added MS 4(0.5 g) and the reaction mixture was cooled to À20 8Cu nder argon. To the cooled reaction mixture were added NIS (110 mg, 0.49 mmol) and HClO 4 ÀSiO 2 (10 mg) and it was allowed to stir at same temperature for 1.5 h. The reaction mixture was filtered and washed with CH 2 Cl 2 (50 mL). The combined organic layer was successively washed with 5% Na 2 S 2 O 3 (50 mL), saturated NaHCO 3 (50 mL) and H 2 O( 50 mL), dried (Na 2 SO 4 )a nd concentrated. The crude product was purified over SiO 2 using hexane/EtOAc (5:1) as eluent to give pure compound One-pot preparation of compound 13:Asolution of compound 6 (250 mg, 0.47 mmol) and compound 7 (350 mg, 0.51 mmol) in dry CH 2 Cl 2 (5 mL) was cooled to À20 8Cu nder argon. To the cooled reaction mixture was added NOBF 4 (40 mg, 0.34 mmol) and it was allowed to stir at same temperature for 1h.A fter consumption of the starting materials [TLC;h exane/EtOAc (6:1)],as olution of compound 10 (250 mg, 0.31 mmol) in CH 2 Cl 2 (3 mL) was added to the reaction mixture followed by NIS (80 mg, 0.36 mmol) and HClO 4 À SiO 2 (10 mg) and it was allowed to stir at À20 8Cf or 1h.T he reaction mixture was filtered and washed with CH 2 Cl 2 (25 mL). The combined organic layer was successively washed with 5% Na 2 S 2 O 3 (25 mL), saturated NaHCO 3 (25 mL) and H 2 O( 25 mL), dried (Na 2 SO 4 ) and concentrated. The crude product was purified over SiO 2 using hexane/EtOAc (5:1) as eluent to give pure compound 13 (260 mg, 46 %int wo steps).
2-(N-
Benzyloxycarbonyl)aminoethyl O-(2,3-di-O-acetyl-4-O-allyl- a-l-rhamnopyranosyl)-(1!3)-4,6-O-benzylidene-2-deoxy-2-N- phthalimido-b-d-glucopyranoside
Benzyloxycarbonyl)aminoethyl O-(2,3-di-O-acetyl-a-l-rham- nopyranosyl)-(1!3)-4,6-O-benzylidene-2-deoxy-2-N-phthalimi- do-b-d-glucopyranoside
Benzyloxycarbonyl)aminoethyl O-(3,4,6-tri-O-benzyl-2- deoxy-2-N-phthalimido-b-d-galactopyranosyl)-(1!4)-O-(2,3-di-O- acetyl-a-l-rhamnopyranosyl)-(1!3)-4,6-O-benzylidene-2-deoxy- 2-N-phthalimido-b-d-glucopyranosideEthyl O-(2,3,5,6-tetra-O-benzyl-a-d-galactofuranosyl)-(1!4)-3,6- di-O-benzyl-2-deoxy-2-N-phthalimido-1-thio-b-d-galactopyrano- side
Benzyloxycarbonyl)aminoethyl O-(2,3,5,6-tetra-O-benzyl-a- d-galactofuranosyl)-(1!4)-O-(3,6-di-O-benzyl-2-deoxy-2-N- phthalimido-b-d-galactopyranosyl)-(1!4)-O-(2,3-di-O-acetyl-a-l- rhamnopyranosyl)-(1!3)-4,6-O-benzylidene-2-deoxy-2-N-phtha- limido-b-d-glucopyranoside
2-Aminoethyl
T oasolution of compound 9 (500 mg, 0.59 mmol) in EtOH (10 mL) was added NH 2 NH 2 ·H 2 O( 0.2 mL) and the mixture was stirred at 80 8Cf or 8h. The solvents were removed under reduced pressure and as olution of the crude mass in acetic anhydride (2 mL) and pyridine (2 mL) was kept at room temperature for 1h.T he solvents were removed under reduced pressure and the crude mass was passed through as hort pad of SiO 2 using EtOAc as eluent. To as olution of the acetylated product in CH 3 OH (10 mL) was added PdCl 2 (80 mg, 0.45 mmol) and the reaction mixture was allowed to stir at room temperature for 1.5 h. The reaction mixture was filtered through aC elite bed, washed with CH 3 OH (25 mL) and concentrated to give the crude product, which was passed through as hort pad of SiO 2 using EtOAc as eluent. To as olution of the de-O-allylated product in CH 3 OH (10 mL) were added 20 %P d(OH) 2 ÀC( 80 mg) and Et 3 SiH (0.4 mL, 2.5 mmol) and the reaction mixture was allowed to stir at room temperature for 12 h. The reaction mixture was filtered through aC elite bed and the filtering bed was washed with CH 3 OH/H 2 O( 10 mL, 2:1 v/v). The combined filtrate was concentrated under reduced pressure and passed through aS ephadex LH-20 column using CH 3 
